Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer

Almost 30% of malignancies in women of developing countries are gynecological and brachytherapy is an integral part of management of these patients. Reports of complications (both acute and late) of high-dose-rate (HDR) intracavitary brachytherapy are sparse in world literature due to relatively sma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of contemporary brachytherapy 2014-10, Vol.6 (3), p.276-281
Hauptverfasser: Gupta, Phalguni, Aich, Ranen Kanti, Deb, Asit Ranjan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 281
container_issue 3
container_start_page 276
container_title Journal of contemporary brachytherapy
container_volume 6
creator Gupta, Phalguni
Aich, Ranen Kanti
Deb, Asit Ranjan
description Almost 30% of malignancies in women of developing countries are gynecological and brachytherapy is an integral part of management of these patients. Reports of complications (both acute and late) of high-dose-rate (HDR) intracavitary brachytherapy are sparse in world literature due to relatively small number of gynecological malignancies, particularly in advanced stage, in developed countries. High-dose-rate brachytherapy is gaining popularity in developing countries due to scientific and economic reasons. Here we are reporting our experience regarding acute complications of intracavitary brachytherapy (events occurring within 30 days of insertion needing hospitalization or death) and their causes to improve the quality of management, so that the already low incidence of acute complications can be further reduced. From February 2004 to December 2012, a total of 1947 patients with uterine cancer were treated by HDR intracavitary brachytherapy in the Department of Radiotherapy, of a tertiary cancer centre of a developing country, 86% of them were cervical cancer and 14% endometrial cancer. Excluding the post-operative patients, a total of 4285 insertions were done in 1527 patients with intact uterus (eligible for analysis) and acute complications were analyzed. Out of 4285 intracavitary brachytherapy insertions in gynecological malignancy patients, only 12 mortality and 239 morbidity instances needing hospitalization were documented and most of them were in cervical carcinoma patients. Our results have indicated that acute complications can be minimized by pre-treatment management of co-morbidities, decreasing the time of operative lithotomy position and bed rest, avoidance of 'conscious sedation' in selected cases etc. Routine post insertion CT scan if done in all patients in all insertions, then only, uterine perforations can be detected early and prompt management can reduce both the mortality and morbidity to a great extent.
doi_str_mv 10.5114/jcb.2014.45493
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4200184</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1615742713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-437a78ef7c34ff36d6132129410d2266444bcb86da67af2032002ecdb089174a3</originalsourceid><addsrcrecordid>eNpdkcFr2zAUh8VoWbJu1x2LoZdenOlJz7J8KYTQdoPCLi2UXYQsy7GCY6WSnZH_fkrblW6nd3jf-_g9foR8BbooAPDbxtQLRgEXWGDFP5A5oxJyJhFOyByErHLJ2eOMfIpxQ6moGC0-khkrOC-BVXPya2mm0WbGb3e9M3p0fohZ6_ve_3bDOnPDGLTRezfqcMg6t-7yxkebB52O6rTqDmNng94dEpolU3BDsunB2PCZnLa6j_bL6zwjDzfX96vv-d3P2x-r5V1uUOKYIy91KW1bGo5ty0UjgLOUDYE2jAmBiLWppWi0KHXLKGeUMmuamsoKStT8jFy9eHdTvbWNscfMvdoFt02hlddO_bsZXKfWfq8wmUBiEly-CoJ_mmwc1dZFY_teD9ZPUYGAokRWAk_oxX_oxk9hSO8dKVpI4LJK1OKFMsHHGGz7FgaoOtamUm3qWJt6ri0dnL9_4Q3_2xP_A24dlKA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1610581389</pqid></control><display><type>article</type><title>Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Gupta, Phalguni ; Aich, Ranen Kanti ; Deb, Asit Ranjan</creator><creatorcontrib>Gupta, Phalguni ; Aich, Ranen Kanti ; Deb, Asit Ranjan</creatorcontrib><description>Almost 30% of malignancies in women of developing countries are gynecological and brachytherapy is an integral part of management of these patients. Reports of complications (both acute and late) of high-dose-rate (HDR) intracavitary brachytherapy are sparse in world literature due to relatively small number of gynecological malignancies, particularly in advanced stage, in developed countries. High-dose-rate brachytherapy is gaining popularity in developing countries due to scientific and economic reasons. Here we are reporting our experience regarding acute complications of intracavitary brachytherapy (events occurring within 30 days of insertion needing hospitalization or death) and their causes to improve the quality of management, so that the already low incidence of acute complications can be further reduced. From February 2004 to December 2012, a total of 1947 patients with uterine cancer were treated by HDR intracavitary brachytherapy in the Department of Radiotherapy, of a tertiary cancer centre of a developing country, 86% of them were cervical cancer and 14% endometrial cancer. Excluding the post-operative patients, a total of 4285 insertions were done in 1527 patients with intact uterus (eligible for analysis) and acute complications were analyzed. Out of 4285 intracavitary brachytherapy insertions in gynecological malignancy patients, only 12 mortality and 239 morbidity instances needing hospitalization were documented and most of them were in cervical carcinoma patients. Our results have indicated that acute complications can be minimized by pre-treatment management of co-morbidities, decreasing the time of operative lithotomy position and bed rest, avoidance of 'conscious sedation' in selected cases etc. Routine post insertion CT scan if done in all patients in all insertions, then only, uterine perforations can be detected early and prompt management can reduce both the mortality and morbidity to a great extent.</description><identifier>ISSN: 1689-832X</identifier><identifier>EISSN: 2081-2841</identifier><identifier>DOI: 10.5114/jcb.2014.45493</identifier><identifier>PMID: 25337129</identifier><language>eng</language><publisher>Poland: Termedia Publishing House</publisher><subject>Original Paper</subject><ispartof>Journal of contemporary brachytherapy, 2014-10, Vol.6 (3), p.276-281</ispartof><rights>Copyright Termedia Publishing House 2014</rights><rights>Copyright © 2014 Termedia 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-437a78ef7c34ff36d6132129410d2266444bcb86da67af2032002ecdb089174a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200184/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200184/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25337129$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gupta, Phalguni</creatorcontrib><creatorcontrib>Aich, Ranen Kanti</creatorcontrib><creatorcontrib>Deb, Asit Ranjan</creatorcontrib><title>Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer</title><title>Journal of contemporary brachytherapy</title><addtitle>J Contemp Brachytherapy</addtitle><description>Almost 30% of malignancies in women of developing countries are gynecological and brachytherapy is an integral part of management of these patients. Reports of complications (both acute and late) of high-dose-rate (HDR) intracavitary brachytherapy are sparse in world literature due to relatively small number of gynecological malignancies, particularly in advanced stage, in developed countries. High-dose-rate brachytherapy is gaining popularity in developing countries due to scientific and economic reasons. Here we are reporting our experience regarding acute complications of intracavitary brachytherapy (events occurring within 30 days of insertion needing hospitalization or death) and their causes to improve the quality of management, so that the already low incidence of acute complications can be further reduced. From February 2004 to December 2012, a total of 1947 patients with uterine cancer were treated by HDR intracavitary brachytherapy in the Department of Radiotherapy, of a tertiary cancer centre of a developing country, 86% of them were cervical cancer and 14% endometrial cancer. Excluding the post-operative patients, a total of 4285 insertions were done in 1527 patients with intact uterus (eligible for analysis) and acute complications were analyzed. Out of 4285 intracavitary brachytherapy insertions in gynecological malignancy patients, only 12 mortality and 239 morbidity instances needing hospitalization were documented and most of them were in cervical carcinoma patients. Our results have indicated that acute complications can be minimized by pre-treatment management of co-morbidities, decreasing the time of operative lithotomy position and bed rest, avoidance of 'conscious sedation' in selected cases etc. Routine post insertion CT scan if done in all patients in all insertions, then only, uterine perforations can be detected early and prompt management can reduce both the mortality and morbidity to a great extent.</description><subject>Original Paper</subject><issn>1689-832X</issn><issn>2081-2841</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdkcFr2zAUh8VoWbJu1x2LoZdenOlJz7J8KYTQdoPCLi2UXYQsy7GCY6WSnZH_fkrblW6nd3jf-_g9foR8BbooAPDbxtQLRgEXWGDFP5A5oxJyJhFOyByErHLJ2eOMfIpxQ6moGC0-khkrOC-BVXPya2mm0WbGb3e9M3p0fohZ6_ve_3bDOnPDGLTRezfqcMg6t-7yxkebB52O6rTqDmNng94dEpolU3BDsunB2PCZnLa6j_bL6zwjDzfX96vv-d3P2x-r5V1uUOKYIy91KW1bGo5ty0UjgLOUDYE2jAmBiLWppWi0KHXLKGeUMmuamsoKStT8jFy9eHdTvbWNscfMvdoFt02hlddO_bsZXKfWfq8wmUBiEly-CoJ_mmwc1dZFY_teD9ZPUYGAokRWAk_oxX_oxk9hSO8dKVpI4LJK1OKFMsHHGGz7FgaoOtamUm3qWJt6ri0dnL9_4Q3_2xP_A24dlKA</recordid><startdate>201410</startdate><enddate>201410</enddate><creator>Gupta, Phalguni</creator><creator>Aich, Ranen Kanti</creator><creator>Deb, Asit Ranjan</creator><general>Termedia Publishing House</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>P5Z</scope><scope>P62</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201410</creationdate><title>Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer</title><author>Gupta, Phalguni ; Aich, Ranen Kanti ; Deb, Asit Ranjan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-437a78ef7c34ff36d6132129410d2266444bcb86da67af2032002ecdb089174a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Original Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gupta, Phalguni</creatorcontrib><creatorcontrib>Aich, Ranen Kanti</creatorcontrib><creatorcontrib>Deb, Asit Ranjan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of contemporary brachytherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gupta, Phalguni</au><au>Aich, Ranen Kanti</au><au>Deb, Asit Ranjan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer</atitle><jtitle>Journal of contemporary brachytherapy</jtitle><addtitle>J Contemp Brachytherapy</addtitle><date>2014-10</date><risdate>2014</risdate><volume>6</volume><issue>3</issue><spage>276</spage><epage>281</epage><pages>276-281</pages><issn>1689-832X</issn><eissn>2081-2841</eissn><abstract>Almost 30% of malignancies in women of developing countries are gynecological and brachytherapy is an integral part of management of these patients. Reports of complications (both acute and late) of high-dose-rate (HDR) intracavitary brachytherapy are sparse in world literature due to relatively small number of gynecological malignancies, particularly in advanced stage, in developed countries. High-dose-rate brachytherapy is gaining popularity in developing countries due to scientific and economic reasons. Here we are reporting our experience regarding acute complications of intracavitary brachytherapy (events occurring within 30 days of insertion needing hospitalization or death) and their causes to improve the quality of management, so that the already low incidence of acute complications can be further reduced. From February 2004 to December 2012, a total of 1947 patients with uterine cancer were treated by HDR intracavitary brachytherapy in the Department of Radiotherapy, of a tertiary cancer centre of a developing country, 86% of them were cervical cancer and 14% endometrial cancer. Excluding the post-operative patients, a total of 4285 insertions were done in 1527 patients with intact uterus (eligible for analysis) and acute complications were analyzed. Out of 4285 intracavitary brachytherapy insertions in gynecological malignancy patients, only 12 mortality and 239 morbidity instances needing hospitalization were documented and most of them were in cervical carcinoma patients. Our results have indicated that acute complications can be minimized by pre-treatment management of co-morbidities, decreasing the time of operative lithotomy position and bed rest, avoidance of 'conscious sedation' in selected cases etc. Routine post insertion CT scan if done in all patients in all insertions, then only, uterine perforations can be detected early and prompt management can reduce both the mortality and morbidity to a great extent.</abstract><cop>Poland</cop><pub>Termedia Publishing House</pub><pmid>25337129</pmid><doi>10.5114/jcb.2014.45493</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1689-832X
ispartof Journal of contemporary brachytherapy, 2014-10, Vol.6 (3), p.276-281
issn 1689-832X
2081-2841
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4200184
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Original Paper
title Acute complications following intracavitary high-dose-rate brachytherapy in uterine cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A29%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20complications%20following%20intracavitary%20high-dose-rate%20brachytherapy%20in%20uterine%20cancer&rft.jtitle=Journal%20of%20contemporary%20brachytherapy&rft.au=Gupta,%20Phalguni&rft.date=2014-10&rft.volume=6&rft.issue=3&rft.spage=276&rft.epage=281&rft.pages=276-281&rft.issn=1689-832X&rft.eissn=2081-2841&rft_id=info:doi/10.5114/jcb.2014.45493&rft_dat=%3Cproquest_pubme%3E1615742713%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1610581389&rft_id=info:pmid/25337129&rfr_iscdi=true